Ceren Yapar Gümüş

Dr. Ceren Yapar Gümüş

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CGCeren Yapar Gümüş
Ceren Yapar Gümüş
TKTaner Kasar
Taner Kasar
MBMeltem Boz
Meltem Boz
EOErkut Ozturk
Erkut Ozturk
Background/Objectives: Elevated troponin levels are widely recognized as key biomarkers of myocardial injury and are frequently used in clinical decision making. However, not all instances of troponin elevation indicate true cardiac damage. In some cases, biochemical or immunological interferences may lead to false-positive results. These situations may lead to unnecessary diagnostic interventions and clinical uncertainty, ultimately impacting patient management negatively. This study aims to investigate the underlying mechanisms of false-positive troponin elevation in pediatric patients, focusing on factors such as macrotroponin formation, autoantibodies, and heterophile antibody interference. Methods: This retrospective study analyzed data from 13 pediatric patients who presented with elevated cardiac troponin levels between 2017 and 2024. Clinical evaluations included transthoracic echocardiography (TTE), electrocardiography (ECG), coronary computed tomography angiography (CTA), cardiac magnetic resonance imaging (MRI), and rheumatologic testing. Laboratory findings included measurements of cardiac troponins (cTnI and hs-cTnT) and pro-BNP levels. Results: Among 70 patients evaluated for elevated troponin levels, 13 (18.6%) were determined to have no identifiable cardiac etiology. The median age of these 13 patients was 13.0 years (range: 9–16), with 53.8% being female. The most common presenting complaints were chest pain (53.8%) and palpitations (30.8%). TTE findings were normal in 61.5% of the patients, and all patients had normal coronary CTA and cardiac MRI findings. Although initial troponin I levels were elevated in all cases, persistent positivity was observed up to 12 months. Median cTnI levels were 1.00 ng/mL (range: 0.33–7.19) at week 1 and 0.731 ng/mL (range: 0.175–4.56) at month 12. PEG precipitation testing identified macrotroponin in three patients (23.1%). No etiological explanation could be identified in 10 cases (76.9%), which were considered idiopathic. All patients had negative results for heterophile antibody and rheumatologic tests. Conclusions: When interpreting elevated troponin levels in children, biochemical interferences—especially macrotroponin—should not be overlooked. This study emphasizes the diagnostic uncertainty associated with non-cardiac troponin elevation. To better guide clinical practice and clarify false positivity rates, larger, multicenter prospective studies are needed.

15 June 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
CGCeren Yapar Gümüş
Ceren Yapar Gümüş
EEEmine Yurdakul Ertürk
Emine Yurdakul Ertürk
YAYeliz Kaşko Arıcı
Yeliz Kaşko Arıcı
EAEcem İpek Altınok
Ecem İpek Altınok
TBTülin Bayrak
Tülin Bayrak
TKTaner Kasar
Taner Kasar
Background: Pediatric acute myocarditis is challenging because presentations range from chest pain to cardiogenic shock, and no single biomarker reflects its inflammatory, ischemic, and hemodynamic components. Ischemia-modified albumin (IMA), a marker of oxidative stress-related alteration in albumin measured by the albumin cobalt-binding assay, has been investigated in ischemic and inflammatory conditions, but its role in pediatric myocarditis remains unclear. Methods: In this prospective, single-center case-control study, 47 children with clinically suspected acute myocarditis and 47 age- and sex-matched healthy controls were evaluated between 1 July 2023 and 1 July 2025. Clinically suspected acute myocarditis was defined according to pediatric guidance as at least one compatible clinical feature together with at least one supportive biomarker, electrocardiographic, or echocardiographic finding after exclusion of alternative diagnoses. IMA levels were measured using the albumin cobalt-binding method and expressed as absorbance units (ABSU). The statistical analysis included between-group comparisons, receiver operating characteristic (ROC) analyses, incremental discrimination analyses, and exploratory clinical severity analyses. Results: IMA concentrations were significantly higher in the myocarditis group than in controls [0.57 (0.55–0.63) vs. 0.55 (0.49–0.59) ABSU, p = 0.021], with a Hodges–Lehmann median difference of 0.04 ABSU (95% CI, 0.01–0.07). However, the diagnostic performance of IMA alone was modest (AUC, 0.64; 95% CI, 0.52–0.75). At the optimal cutoff of 0.53 ABSU, sensitivity was 89.36% and specificity was 38.30%. Conventional biomarkers showed stronger discrimination, including troponin I (AUC, 0.96), troponin T (AUC, 0.93), NT-proBNP (AUC, 0.88), CRP (AUC, 0.85), and CK-MB (AUC, 0.83). A base model including CK-MB, NT-proBNP, and CRP yielded an AUC of 0.92; adding IMA increased the AUC marginally to 0.93 (delta AUC, 0.01; p = 0.153). All children in the clinically suspected myocarditis group were symptomatic at presentation, and exploratory analyses showed no significant association between IMA and selected electrocardiographic or echocardiographic abnormalities or length of hospital stay. Conclusion: IMA is elevated in children with clinically suspected acute myocarditis, but its standalone diagnostic performance is limited and its added value beyond conventional biomarkers appears small. IMA may be considered an adjunctive rather than a primary diagnostic biomarker, and any putative triage role in ultra-early presentations remains hypothesis-generating.

31 May 2025 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Open access
PDF file
EAEcem İpek Altınok
Ecem İpek Altınok
CGCeren Yapar Gümüş
Ceren Yapar Gümüş
Objective: Anaphylaxis should be recognized and treated by physicians and healthcare workers. In our study, we aimed to determine the knowledge and education levels regarding anaphylaxis and the attitudes towards adrenaline auto-injector use among doctors, nurses, and health technicians working in the Women's and Children's Annex of Ordu University Training and Research Hospital, a tertiary healthcare institution. Method: A 15-item questionnaire designed to assess demographic data, employment status, and knowledge level about anaphylaxis and its management was administered to the participants. Results: The study was completed with 136 participants, including 66 physicians, 58 nurses, and 12 technicians. It was found that 75 participants had knowledge about adrenaline auto-injectors, with 9.3% having previously issued a report on auto-injectors. Physicians showed greater knowledge in correctly administering adrenaline during anaphylaxis compared to other professional groups. Healthcare workers in the emergency department demonstrated higher levels of knowledge in adrenaline administration compared to those in other units. While no significant relationship was found between professional experience and the selection of correct treatment methods in anaphylaxis, those with longer professional lives were found to have better knowledge about adrenaline administration proportionally. Another finding from our study is that participants who received training within less than 3 years had more accurate knowledge about adrenaline administration compared to others. Conclusion: The repetition of essential training and keeping knowledge up-to-date are crucial for correct application and treatment in anaphylaxis. There is a need for organizing training sessions to increase knowledge levels and awareness, particularly among healthcare workers, including physicians.

25 February 2022 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Closed access
CGCeren Yapar Gümüş
Ceren Yapar Gümüş
NENurdan Erol
Nurdan Erol
NKNihan Uygur külcü
Nihan Uygur külcü
Objective: This study aimed to investigate the relationship between Kawasaki syndrome and viral infections.Methods: The data of the Kawasaki syndrome cases diagnosed between January 2017 to December 2019 were reviewed from hospital records retrospectively.Results: Among eighteen cases ten were boys, and eight were girls. Their average age at diagnosis was 38.28 ± 28.38 (3-113 months). Seven cases were in winter, eight in spring and autumn, and three in summer diagnosed. The mean length of stay in the hospital was 7.41±3.34 (3-17 days). All patients presented with fever, and the mean duration of fever was 6.94 ± 1.63 days. Six cases were classified as typical KS (33.3%), and twelve as atypical KS (66.7%). Laboratory examinations revealed a leukocyte count of 16507 ± 61817 /mm³, C-reactive protein 8.59 ±5.87 mg/dl, erythrocyte sedimentation rate (ESR) median value 58 mm/hour (18-102). Fourteen patients had cardiac involvement (pericardial effusion, mitral insufficiency), and six had small coronary artery involvement. Both cardiac and coronary artery involvement rates were higher in the atypical KS. In only six cases (33.3%) were the pathogens detected. The detected infectious agents were: Parainfluenza type 4, Parainfluenza type 3, Respiratory syncytial virus, Group A streptococcus, Epstein-Barr virus, Ochrobactrumanthropi, Rubella, Cytomegalovirus. Conclusion: Detection of infectious agents in only one-third of the cases and the presence of different factors suggest that the Kawasaki syndrome is not related to a specific pathogenic agent. Coronary involvement was not found to be associated with pathogenic agents. However, atypical KS needs more attention for cardiac involvement.

27 April 2026 in Medical Science Monitor
Verified
Journal Article
Open access
CGCeren Yapar Gümüş
Ceren Yapar Gümüş
YÖYavuz Özer
Yavuz Özer
YAYeliz Kaşko Arıcı
Yeliz Kaşko Arıcı
Retrospective Study of Serum Vitamin D Levels and Metabolic-Associated Fatty Liver Disease in 222 Children and Adolescents Aged 6-18 Years With Obesity - Article abstract #952489